Today, the Senate Committee on Health, Education, Labor and Pensions (HELP) voted to report out the bipartisan Opioid Crisis Response Act of 2018.
WASHINGTON, DC – Today, the Senate Committee on Health, Education, Labor and Pensions (HELP) voted to report out the bipartisan Opioid Crisis Response Act of 2018, introduced by Chairman Lamar Alexander and Ranking Member Patty Murray. Shatterproof Founder and CEO Gary Mendell issued the following statement in response.
“The Senate HELP Committee today made important progress in the fight against the opioid crisis by advancing this bipartisan legislation. We welcome the provisions to establish Comprehensive Opioid Recovery Centers and improve existing state Prescription Drug Monitoring Programs (PDMPs). We are also pleased to see amendments from Senator Maggie Hassan and Senator Rand Paul added to the bill since they will help to broaden access to medication-assisted treatment (MAT). As the bill moves to the full Senate, we urge senators to continue to improve upon the bill by including provisions to limit opioid prescriptions for acute pain to three days, require states to meet minimum best practices for PDMPs, and incentivize evidence-based approaches to treating substance use disorders. If passed, these smart, common-sense provisions will start saving lives immediately.”
About Gary Mendell:
Gary Mendell is the founder and CEO of Shatterproof. He founded Shatterproof to spare others the tragedy his family suffered with the loss of his son Brian to addiction in 2011. Mr. Mendell is an experienced businessman and CEO who founded HEI Hotels & Resorts and is the former president of Starwood Lodging Trust.
Shatterproof is a national nonprofit organization dedicated to reducing the devastation the disease of addiction causes families. Shatterproof works to end the stigma and foster a community of support, providing evidence-based resources to support prevention, treatment and recovery. Shatterproof advocates for changes in policy at the federal and state level and supports the development and implementation of evidence-based solutions for substance use disorders.